Glaxosmithkline

Showing of 1 - 20 from 43 results
Glaxosmithkline - Total results - 43
Sanofi and GlaxoSmithKline snag $2.1 billion funding from US govt in biggest coronavirus vaccine deal yet
World

Sanofi and GlaxoSmithKline snag $2.1 billion funding from US govt in biggest coronavirus vaccine deal yet

The arrangement brings the Trump administration’s investment in coronavirus vaccine projects to more than $8 billion.

Pfizer CEO says COVID-19 vaccine likely to be ready by October this year; 'will have enough evidence of safety, efficacy'
Business

Pfizer CEO says COVID-19 vaccine likely to be ready by October this year; 'will have enough evidence of safety, efficacy'

Pfizer is working with German firm Biontech for several possible vaccines in Europe and the United States, said the report.

Sanofi will enroll thousands of subjects to participate in its Coronavirus vaccine trials in order to get data sooner
World

Sanofi will enroll thousands of subjects to participate in its Coronavirus vaccine trials in order to get data sooner

Late-stage trials with thousands of subjects comparing the vaccine to placebo are expected to take place by year-end or early 2021.

Unilever withdraws growth outlook; says India business impacted by slowing market, coronavirus-forced lockdown
Business

Unilever withdraws growth outlook; says India business impacted by slowing market, coronavirus-forced lockdown

Unilever witnessed a major impact on the businesses in China and India, two of its major markets where restrictions were imposed by the respective governments to contain the spread of COVID-19.

Indian generic drugmakers may face supply shortages from China if coronavirus drags on: Report
Business

Indian generic drugmakers may face supply shortages from China if coronavirus drags on: Report

An important supplier of generic drugs to the world, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.

Researchers find a compound that can halt growth of parasite that causes malaria
science

Researchers find a compound that can halt growth of parasite that causes malaria

Apparently, a compound developed by GlaxoSmithKline can eliminate the mosquito-borne parasite in all the stages of its lifecycle.

CCI approves GlaxoSmithKline, Pfizer consumer healthcare joint venture
Business

CCI approves GlaxoSmithKline, Pfizer consumer healthcare joint venture

The Competition Commission on Friday said it has approved the formation of a joint venture for consumer healthcare products by pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer

Pfizer to shut down two plants in India citing unviability; decision leaves about 1,700 employees in lurch
Business

Pfizer to shut down two plants in India citing unviability; decision leaves about 1,700 employees in lurch

Pfizer will soon shut down its plants in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing lack of viability.

GSK and Pfizer to combine consumer health businesses; British drugmaker plans to split into two businesses
Business

GSK and Pfizer to combine consumer health businesses; British drugmaker plans to split into two businesses

GSK said the deal laid the foundation for the creation of two new UK-based global companies focused on pharmaceuticals/vaccines and consumer healthcare

Unilever CEO Paul Polman steps down after headquarters move fiasco, replaced by insider Alan Jope
Business

Unilever CEO Paul Polman steps down after headquarters move fiasco, replaced by insider Alan Jope

A UK investor revolt forced Polman and the Unilever board to scrap a plan in October to move the headquarters of the dual-listed company to the Netherlands

GSK Consumer Healthcare says it is considering potential transaction of nutrition business; Unilever confirms development
Business

GSK Consumer Healthcare says it is considering potential transaction of nutrition business; Unilever confirms development

Hindustan Unilever, the Indian arm of Unilever, confirmed that the company was in the race to acquire GlaxoSmithKline Plc's consumer healthcare nutrition products

Unilever emerges as leading bidder in tight contest for GlaxoSmithKline's Horlicks nutrition business
Business

Unilever emerges as leading bidder in tight contest for GlaxoSmithKline's Horlicks nutrition business

GSK’s assets, which include the popular malt-based drinks Horlicks and Boost, is likely to fetch less than $4 billion, said people close the deal

Coca-Cola in race to buy Horlicks from GlaxoSmithKline, value of transaction could be around $3.9 billion
Business

Coca-Cola in race to buy Horlicks from GlaxoSmithKline, value of transaction could be around $3.9 billion

Besides Coca-Cola, several global FMCG makers as Nestle, Kraft Heinz are in the race to acquire Horlicks from GSK

Glenmark Pharma pushes first generic product in Europe with asthma drug in Denmark
Business

Glenmark Pharma pushes first generic product in Europe with asthma drug in Denmark

Glenmark said it has already received National Marketing Authorizations for the product in Sweden, Finland, Norway and Iceland.

Google parent Alphabet and GlaxoSmithKline form a new company
News & Analysis

Google parent Alphabet and GlaxoSmithKline form a new company

GlaxoSmithKline and Google parent Alphabet's life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics.

 Sun Pharma to buy GSK's opiates business in Australia
Business

Sun Pharma to buy GSK's opiates business in Australia

The business includes two manufacturing sites in Tasmania and Victoria, and consists of poppy-derived opiate raw materials mainly used to make analgesics for pain treatment.

Sun Pharma to buy GSK's opiates business in Australia, stock up
Business

Sun Pharma to buy GSK's opiates business in Australia, stock up

Sun Pharmaceutical Industries, India's largest drugmaker by sales, said on Tuesday it has agreed to buy GlaxoSmithKline's opiates business in Australia.

Lupin ties up with Poland-based firm to develop generic asthama drug
Business

Lupin ties up with Poland-based firm to develop generic asthama drug

Lupin has inked a pact with Poland-based Celon Pharma to jointly develop and market a generic version GlaxoSmithKline's Advair Diskus, a drug used to treat asthama, in global markets.

GlaxoSmithKline says it will axe hundreds of jobs in US
International

GlaxoSmithKline says it will axe hundreds of jobs in US

Many of the jobs lost will be from GSK's Research Triangle Park site in North Carolina as drug research is consolidated in Philadelphia and in Stevenage, near London.<br />

Glaxo's experimental Ebola vaccine passes early safety test
World

Glaxo's experimental Ebola vaccine passes early safety test

Researchers assess the effectiveness of candidate vaccines by whether they trigger production of anti-Ebola antibodies and immune-system T cells.